| Primary |
| Psoriasis |
75.4% |
| Seborrhoeic Dermatitis |
6.2% |
| Pityriasis Rubra Pilaris |
4.6% |
| Product Used For Unknown Indication |
4.6% |
| Drug Exposure During Pregnancy |
1.5% |
| Hepatitis |
1.5% |
| Ichthyosis |
1.5% |
| Psoriatic Arthropathy |
1.5% |
| Pustular Psoriasis |
1.5% |
| Supplementation Therapy |
1.5% |
|
| Psoriasis |
14.3% |
| Nephrolithiasis |
11.4% |
| Photosensitivity Reaction |
8.6% |
| Angina Pectoris |
5.7% |
| Dermatitis Contact |
5.7% |
| Hypersensitivity |
5.7% |
| Maternal Drugs Affecting Foetus |
5.7% |
| Skin Cancer |
5.7% |
| Skin Test Positive |
5.7% |
| Accidental Drug Intake By Child |
2.9% |
| Application Site Reaction |
2.9% |
| Blood Pressure Increased |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Death |
2.9% |
| Dermatitis |
2.9% |
| Emotional Distress |
2.9% |
| Erythema |
2.9% |
| Feeling Hot |
2.9% |
| Hand Deformity |
2.9% |
| Hypercalcaemia |
2.9% |
|
| Secondary |
| Psoriasis |
70.6% |
| Hepatitis |
7.8% |
| Constipation |
3.9% |
| Anxiety |
2.0% |
| Back Pain |
2.0% |
| Breakthrough Pain |
2.0% |
| Depression |
2.0% |
| Herpes Zoster |
2.0% |
| Hypertension |
2.0% |
| Muscle Spasms |
2.0% |
| Neuralgia |
2.0% |
| Thyroid Disorder |
2.0% |
|
| Nephrolithiasis |
17.6% |
| Psoriasis |
17.6% |
| Thermal Burn |
11.8% |
| Cellulitis |
5.9% |
| Dermatitis Contact |
5.9% |
| Photosensitivity Reaction |
5.9% |
| Rebound Effect |
5.9% |
| Rectal Cancer |
5.9% |
| Skin Test Positive |
5.9% |
| Toxicity To Various Agents |
5.9% |
| Vitamin B12 Decreased |
5.9% |
| Weight Increased |
5.9% |
|
| Concomitant |
| Psoriasis |
38.4% |
| Product Used For Unknown Indication |
21.9% |
| Psoriatic Arthropathy |
12.0% |
| Drug Use For Unknown Indication |
4.8% |
| Prophylaxis |
4.2% |
| Hypertension |
2.9% |
| Pain |
2.1% |
| Hepatitis C |
1.7% |
| Diabetes Mellitus |
1.6% |
| Depression |
1.5% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Pustular Psoriasis |
1.2% |
| Insomnia |
1.1% |
| Antipyresis |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Rheumatoid Arthritis |
0.9% |
| Antibiotic Prophylaxis |
0.6% |
| Anxiety |
0.6% |
| Type 2 Diabetes Mellitus |
0.6% |
| Hypersensitivity |
0.6% |
|
| Psoriasis |
13.3% |
| Injection Site Pain |
6.9% |
| Weight Decreased |
6.9% |
| Hepatic Function Abnormal |
6.4% |
| Myocardial Infarction |
6.4% |
| Drug Ineffective |
5.8% |
| Nasopharyngitis |
5.2% |
| Pyrexia |
5.2% |
| Histiocytosis Haematophagic |
4.6% |
| Pain |
4.6% |
| Skin Tightness |
4.6% |
| Weight Increased |
4.6% |
| Homicide |
3.5% |
| Urinary Tract Infection |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| White Blood Cell Count Increased |
3.5% |
| Arthralgia |
2.9% |
| Infection |
2.9% |
| Liver Disorder |
2.9% |
| Pneumocystis Jiroveci Pneumonia |
2.9% |
|
